Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Haasen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
Cell Reports|February 21, 2020
A High-Throughput Screening Identifies MICU1 Targeting CompoundsGiulia Di Marco, Francesca Vallese, Benjamin Jourde, et al.
Cancer Research|June 24, 2011
A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patientsRalph Tiedt, Elisa Degenkolbe, Pascal Furet, et al.
Nature|November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical propertiesKlemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
Cell Reports|February 21, 2020
A High-Throughput Screening Identifies MICU1 Targeting CompoundsGiulia Di Marco, Francesca Vallese, Benjamin Jourde, et al.
Cancer Research|June 24, 2011
A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patientsRalph Tiedt, Elisa Degenkolbe, Pascal Furet, et al.
Nature|November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.
Pageof 2